New blood test could spot dangerous prostate cancer without a biopsy

NCT ID NCT07492927

Recruiting now Diagnosis Sponsor: Xijing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test that looks for genetic material from tiny particles called exosomes to diagnose aggressive prostate cancer. The goal is to see if this test can accurately identify men who need a biopsy, avoiding unnecessary procedures. Researchers plan to enroll 1700 men with elevated PSA or other signs of prostate cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: plasma exosome RNA panel (blood test)
What this could lead to: If successful, this blood test could provide a non-invasive way to diagnose aggressive prostate cancer, potentially reducing the need for invasive biopsies.
What could go wrong: This is a diagnostic study, not a treatment. The test may not be accurate enough to replace current methods, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICALLY SIGNIFICANT PROSTATE CANCER

Contacts and locations

Locations

General Hospital of Ningxia Medical University
RECRUITING

Yinchuan, Ningxia, China
Northwestern Memorial Hospital
RECRUITING

Chicago, Illinois, 60611, United States
Qinghai University Affiliated Hospital
RECRUITING

Xining, Qinghai, China
Shaanxi Provincial People's Hospital
RECRUITING

Xi'an, Shaanxi, China
The First Hospital of Lanzhou University
RECRUITING

Lanzhou, Gansu, China
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
RECRUITING

Xianyang, Shaanxi, China
Weinan Central Hospital
RECRUITING

Weinan, Shaanxi, China
Xijing 986 Hospital
RECRUITING

Xi'an, Shaanxi, China
Xijing Hospital
RECRUITING

Xi'an, 710032, China
Yan'an University Affiliated Hospital
RECRUITING

Yan’an, Shaanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.